{
    "pmcid": "9941073",
    "qa_pairs": {
        "How do nanobodies contribute to the detection of the SARS-CoV-2 spike protein in biosensors?": [
            "They are immobilized on sensor surfaces to capture the S protein.",
            "They degrade the S protein to facilitate detection.",
            "They act as a secondary signal amplifier in the detection process.",
            "They replace the need for any transduction methods."
        ],
        "What is a significant challenge in designing nanobody binders for the SARS-CoV-2 spike protein?": [
            "Ensuring specificity without cross-reactivity to other coronaviruses.",
            "Achieving high production costs.",
            "Maintaining large molecular size for better binding.",
            "Reducing stability in various environmental conditions."
        ],
        "What is the primary function of the S1 subunit of the SARS-CoV-2 spike protein?": [
            "It contains the receptor-binding domain (RBD) that interacts with ACE2.",
            "It is involved in membrane fusion.",
            "It forms the intracellular tail of the spike protein.",
            "It acts as a stabilizing structure for the ectodomain."
        ],
        "What is the role of the S2 subunit in the SARS-CoV-2 spike protein?": [
            "It is involved in membrane fusion, allowing viral genome entry.",
            "It contains the receptor-binding domain (RBD).",
            "It forms the large ectodomain of the spike protein.",
            "It interacts directly with the host cell receptor ACE2."
        ],
        "Why are nanobodies considered advantageous for use in biosensing applications?": [
            "They are stable, cost-effective to produce, and have high tissue penetration.",
            "They are larger and more complex than conventional antibodies.",
            "They require mammalian cell systems for production.",
            "They are less specific than conventional antibodies."
        ]
    }
}